PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY

通过质谱法进行抗原表征

基本信息

  • 批准号:
    6534032
  • 负责人:
  • 金额:
    $ 48.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-09-01 至 2004-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (adapted from applicant's abstract) Research to continue the development of instrumentation and methods for the sequence analysis of peptide antigens presented to the immune system in association with class I and class II molecules of the major histocompatibility complex is proposed. Routine detection and characterization of disease associated antigens present at the attomole level in a mixture of 10,000 self peptides is the expected outcome. Identification of disease associated antigens is an important first step in the development of vaccines or other immune system modulators that are effective against bacterial and viral infections, cancer, autoimmune disorders and tissue transplant rejection. Multistage chromatography in conjunction with our recently developed, automated peak parking technology plus nanoliter/min, high performance liquid chromatography and high performance capillary electrophoresis interfaced to an ion trap mass spectrometer via an electrospray ionization source will be employed to achieve this goal. Specific aims of the proposed research include the following: (1) to identify melanoma specific antigens presented by the class I molecules, HLA A2.1, A1 and A3, and the class II molecule, DR4, (2) to identify minor histocompatibility antigens associated with graft-vs-host disease and tissue transplant rejection, (3) to identify peptides derived from myelin basic protein as well as cross reactive self peptides that are presented by the multiple sclerosis associated class II molecule, DR15Dw2, and recognized by T-cell clones derived from multiple sclerosis patients, (4) to identify peptides presented by the class I molecule, B27, that are unique to individuals diagnosed with ankylosing spondylitis (5) to identify peptides presented by the class I molecule, A2.1, that are unique to individuals diagnosed as having chronic lymphocytic leukemia, (6) to identify and characterize peptides presented by HLA-A2.1, that have been post translationally modified by either phosphorylation or glycosylation, (7) to identify class II peptides presented by the HLA-DR4Dw4 molecule in the presence and absence of the chaperone molecule, HLA-DM.
描述:(改编自申请人摘要)继续研究

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DONALD F HUNT其他文献

DONALD F HUNT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DONALD F HUNT', 18)}}的其他基金

PROTEOMIC
蛋白质组学
  • 批准号:
    7313421
  • 财政年份:
    2006
  • 资助金额:
    $ 48.38万
  • 项目类别:
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
通过质谱法进行抗原表征
  • 批准号:
    6373317
  • 财政年份:
    1999
  • 资助金额:
    $ 48.38万
  • 项目类别:
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
通过质谱法进行抗原表征
  • 批准号:
    6653813
  • 财政年份:
    1999
  • 资助金额:
    $ 48.38万
  • 项目类别:
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
通过质谱法进行抗原表征
  • 批准号:
    6943743
  • 财政年份:
    1999
  • 资助金额:
    $ 48.38万
  • 项目类别:
Processed Antigen Characterization by Mass Spectrometry
通过质谱分析处理抗原表征
  • 批准号:
    8115926
  • 财政年份:
    1999
  • 资助金额:
    $ 48.38万
  • 项目类别:
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
通过质谱法进行抗原表征
  • 批准号:
    2697497
  • 财政年份:
    1999
  • 资助金额:
    $ 48.38万
  • 项目类别:
Processed Antigen Characterization by Mass Spectrometry
通过质谱分析处理抗原表征
  • 批准号:
    7917390
  • 财政年份:
    1999
  • 资助金额:
    $ 48.38万
  • 项目类别:
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
通过质谱法进行抗原表征
  • 批准号:
    6170021
  • 财政年份:
    1999
  • 资助金额:
    $ 48.38万
  • 项目类别:
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
通过质谱法进行抗原表征
  • 批准号:
    6911650
  • 财政年份:
    1999
  • 资助金额:
    $ 48.38万
  • 项目类别:
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
通过质谱法进行抗原表征
  • 批准号:
    7456406
  • 财政年份:
    1999
  • 资助金额:
    $ 48.38万
  • 项目类别:

相似海外基金

Elucidating a molecular understanding of ILC2 MHC class I antigen cross priming
阐明 ILC2 MHC I 类抗原交叉引发的分子理解
  • 批准号:
    486527
  • 财政年份:
    2022
  • 资助金额:
    $ 48.38万
  • 项目类别:
    Studentship Programs
Restoring MHC class I antigen presentation to enhance anti-tumour immunity
恢复MHC I类抗原呈递,增强抗肿瘤免疫力
  • 批准号:
    nhmrc : GNT1164054
  • 财政年份:
    2020
  • 资助金额:
    $ 48.38万
  • 项目类别:
    Project Grants
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
  • 批准号:
    8996707
  • 财政年份:
    2014
  • 资助金额:
    $ 48.38万
  • 项目类别:
Ubiquitin conjugation and direct MHC class I antigen presentation
泛素结合和直接 MHC I 类抗原呈递
  • 批准号:
    8880646
  • 财政年份:
    2014
  • 资助金额:
    $ 48.38万
  • 项目类别:
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
  • 批准号:
    9206412
  • 财政年份:
    2014
  • 资助金额:
    $ 48.38万
  • 项目类别:
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
  • 批准号:
    8723605
  • 财政年份:
    2014
  • 资助金额:
    $ 48.38万
  • 项目类别:
MHC Class I Antigen Presentation in Viral Infections
病毒感染中 MHC I 类抗原呈递
  • 批准号:
    8072956
  • 财政年份:
    2010
  • 资助金额:
    $ 48.38万
  • 项目类别:
The function of the Ubiquitin-Proteasome-System (UPS) in MHC class I antigen processing in target cells and maturing human dendritic cells (hDCs).
泛素蛋白酶体系统 (UPS) 在靶细胞和成熟人树突细胞 (hDC) 中 MHC I 类抗原加工中的功能。
  • 批准号:
    105348415
  • 财政年份:
    2009
  • 资助金额:
    $ 48.38万
  • 项目类别:
    Research Grants
In vivo analysis of the imnportance of proteasome immunosubunits and of PA28 for MHC class I antigen processing, CTL response induction and tumor-virus elimination (A 7)
体内分析蛋白酶体免疫亚基和 PA28 对于 MHC I 类抗原加工、CTL 反应诱导和肿瘤病毒消除的重要性 (A 7)
  • 批准号:
    5354871
  • 财政年份:
    2002
  • 资助金额:
    $ 48.38万
  • 项目类别:
    Collaborative Research Centres
MHC Class I Antigen Presentation in Viral Infections
病毒感染中 MHC I 类抗原呈递
  • 批准号:
    7991835
  • 财政年份:
    2001
  • 资助金额:
    $ 48.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了